Graft Polymer Appoints Biotech Veteran as Chairman
Company Announcements

Graft Polymer Appoints Biotech Veteran as Chairman

Graft Polymer (UK) PLC (GB:GPL) has released an update.

Graft Polymer (UK) PLC announces the appointment of biotechnology industry veteran Dennis Purcell as its new Chairman, succeeding Nicholas Nelson. Purcell, renowned for his leadership at Aisling Capital and expertise in healthcare investment, is set to steer the company’s strategic partnerships, starting with a collaboration with Awakn Life Sciences to develop treatments for mental health disorders like PTSD. In recognition of his new role, Purcell has been granted 45 million options under the company’s Long Term Incentive Plan.

For further insights into GB:GPL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskGraft Polymer Advances PTSD Therapeutic Research
TipRanks UK Auto-Generated NewsdeskGraft Polymer Advances PTSD Treatment Research
TipRanks UK Auto-Generated NewsdeskGraft Polymer Welcomes New Chairman
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App